News Briefs

Kaiser Permanente is joining Civica Rx – the not-for-profit generic drug company run by health systems and hospitals — as a governing member with a seat on the board of directors. Civica, which was founded in 2018 in a bid to address shortages of critical drugs, is already manufacturing 20 essential generic medications — “10 of which are currently being used to treat COVID-19 patients,” the organizations noted in a June 18 press release. “The COVID-19 pandemic has put a spotlight on the critical need for ensuring consistent supplies of affordable, generic medications for patients and we are proud to join with Civica Rx to help lead these efforts,” Kaiser Permanente Chairman and CEO Greg Adams said. Visit https://prn.to/37JMNDQ.

Humana Inc. said it’s teaming up with a company called Pharmacy Quality Solutions (PQS) on a pilot program that aims to improve outcomes for diabetes patients. Using PQS’s EQuIPP platform, select pharmacies in Arizona, Iowa, Kentucky, North Carolina, Ohio and Texas that serve Humana Medicare Advantage members with a prescription drug benefit will be able to track the performance of their patients on two quality measures, Diabetes Control — A1c Testing and Diabetes Control — A1c Under Control, through the 2020 program year. “For pharmacies, higher performance scores will correspond to greater incentives,” a press release stated. Read more at https://bwnews.pr/2CibImo.

© 2024 MMIT
AIS Health Staff

AIS Health Staff

Related Posts

pills
April 25

Expiring Policies Threaten Progress on Opioid Use Disorder Med Uptake

READ MORE
businessman-viewing-news-update-journalism-headline-on-a-laptop
April 25

News Briefs: CarelonRx Launches New Specialty Offering

READ MORE
iv-injection
April 25

Analysis Tallies Premium Impact of Provider Markups on Specialty Drugs

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today